Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters

Successful development of a chemoprophylaxis against SARS-CoV-2 could provide a tool for infection prevention implementable alongside vaccination programmes. Camostat and nafamostat are serine protease inhibitors that inhibit SARS-CoV-2 viral entry in vitro but have not been characterised for chemop...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:bioRxiv
Autores principales: Neary, M, Box, H, Sharp, J, Tatham, L, Curley, P, Herriott, J, Kijak, E, Arshad, U, Hobson, JJ, Rajoli, RKR, Pertinez, H, Valentijn, A, Dhaliwal, K, McCaughan, F, Rannard, SP, Kipar, A, Stewart, JP, Owen, A
Formato: Artigo
Lenguaje:Inglês
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282100/
https://ncbi.nlm.nih.gov/pubmed/34268511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.07.08.451654
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares